AbbVie Inc 10-K for FY2024

Headline figures

Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue

$56.33B

up 3.7% from $54.32B a year earlier

Net income

$4.28B

down 12.0% from net income of $4.86B a year earlier

Diluted EPS

$2.39

down 12.1% from $2.72 a year earlier